首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Therapeutic Advances In Drug Safety

Therapeutic Advances In Drug Safety杂志,由SAGE出版,于2010年创刊,1 issue/year,出版语言English,ISSN:2042-0986,E-ISSN:2042-0994。

投稿咨询
Therapeutic Advances In Drug Safety
Therapeutic Advances In Drug Safety
Therapeutic Advances In Drug Safety
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
2区
影响因子
3.3
CiteScore
4.6
期刊收录
SCI、SCIE

Therapeutic Advances In Drug Safety(中文译名:《药物安全的治疗进展》),ISSN:2042-0986,EISSN:2042-0994,是SAGE出版的国际性学术期刊,创刊于2010年,以1 issue/year形式稳定发行,2026年总发文量约64篇。该刊采用OA开放访问,学科归属为Medicine - Pharmacology (medical)。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.3,2025年期刊CiteScore为4.6,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Therapeutic Advances In Drug Safety长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期9 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAAustralia、England、Canada、Denmark、Italy、Spain等为核心发文国家与地区;MONASH UNIVERSITYUNIVERSITY OF SYDNEY、FLINDERS MEDICAL CENTRE、ROYAL ADELAIDE HOSPITAL、UNIVERSITY OF ABERDEEN、UNIVERSITY OF ADELAIDE、UNIVERSITY OF COLORADO SYSTEM等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 149 / 356

58.3

学科:PHARMACOLOGY & PHARMACY SCIE Q2 135 / 356

62.22

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 105 / 354

70.5

学科:PHARMACOLOGY & PHARMACY SCIE Q2 160 / 354

54.94


中国学者近期发文

1
Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS databas

Author:Lv, Bo; Han, Junping; Yu, Yunli; Li, Yuedong

Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986261438241

2
Incidence, risk factors, and prediction model of piperacillin/tazobactam-associated hypokalemia in neonate

Author:Wan, Jun; Lin, Shiteng; Zhuang, Wei; Chen, Weida; Huang, Yanting; Huang, Zhiyi; Lin, Wanlong; Chen, Yao

Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986261434697

3
Metformin-associated lactic acidosis in an elderly diabetic patient without classical risk factors: a case repor

Author:Zheng, Yali; Sun, Jia; Zhang, Peng; Zhu, Quanfeng

Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986261428996

4
Drug-induced intestinal obstruction: insights from the FDA Adverse Event Reporting Syste

Author:Li, He; Li, Yingjie; Liu, Lu; Zeng, Bing; Su, Sihui; Liu, Jianjian; Pan, Chun; Li, Tianlong

Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986251414836

5
Donor and recipient genetic polymorphisms modulate tacrolimus pharmacokinetics during voriconazole co-therapy: a drug-drug interaction study in liver transplant recipient

Author:Li, Jieling; Li, Liubing; Xia, Yanzhe; Chen, Jie; Li, Jiali; Lin, Xiaobin; Chen, Xiao; Tang, Ke-Jing; Chen, Pan; Liu, Xiaoman

Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986261420282

6
Disparities and trends in drug-related adverse reaction mortality in the United States, 1999-202

Author:Guo, Liwei; Dong, Xiuxun

Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986261421278

7
Effect of ciprofol-assisted sedation on tourniquet-related responses in foot and ankle surgery: a randomized clinical tria

Author:Ma, Yaoyang; Zhu, Bingqing; Wang, Shudong; Lu, Danjun; Yan, Wenlong; Yu, Yi; Cao, Ying; Kang, Fang; Li, Juan

Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2026; Vol. 17, Issue , pp. -. DOI: 10.1177/20420986251414580

8
Pharmacovigilance analysis of secondary primary malignancies and antibiotic interactions in CAR-T cell therapie

Author:Peng, Yun; Song, Yuxuan; Lin, Jiaxing; Qin, Caipeng; Du, Yiqing; Xu, Tao

Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2025; Vol. 16, Issue , pp. -. DOI: 10.1177/20420986251340866

9
Beyond pain relief: the thrombosis threat of celecoxi

Author:Di, Jingkai; Xi, Yujia; Qi, Likun; Zhao, Yicong; Guo, Zijian; Yang, Nan; Xiang, Chuan

Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2025; Vol. 16, Issue , pp. -. DOI: 10.1177/20420986251347354

10
Pharmacovigilance analysis of small bowel bleeding associated with NSAID

Author:Deng, Ying-Han; Jiang, Meiting; Chen, Yun; Chen, Hong-Bin

Journal: THERAPEUTIC ADVANCES IN DRUG SAFETY. 2025; Vol. 16, Issue , pp. -. DOI: 10.1177/20420986251318848


在线咨询

Therapeutic Advances In Drug Safety

国际简称:THER ADV DRUG SAF参考译名:药物安全的治疗进展

年发文量:64 CiteScore:4.6 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:82.81%

杂志社联系方式:1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP

Therapeutic Advances In Drug Safety